These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 11279638)

  • 1. Lactate dehydrogenase production and release in a newly established human myeloma cell line.
    Hatakeyama N; Daibata M; Nemoto Y; Ohtsuki Y; Taguchi H
    Am J Hematol; 2001 Apr; 66(4):267-73. PubMed ID: 11279638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment of a CD45-positive immature plasma cell line from an aggressive multiple myeloma with high serum lactate dehydrogenase.
    Hata H; Matsuzaki H; Sonoki T; Takemoto S; Kuribayashi N; Nagasaki A; Takatsuki K
    Leukemia; 1994 Oct; 8(10):1768-73. PubMed ID: 7934174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitation of multiple myeloma oncogene 1/interferon-regulatory factor 4 gene expression in malignant B-cell proliferations and normal leukocytes.
    Yamada M; Asanuma K; Kobayashi D; Moriai R; Yajima T; Yagihashi A; Yamamori S; Watanabe N
    Anticancer Res; 2001; 21(1B):633-8. PubMed ID: 11299818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteopontin is an adhesive factor for myeloma cells and is found in increased levels in plasma from patients with multiple myeloma.
    Standal T; Hjorth-Hansen H; Rasmussen T; Dahl IM; Lenhoff S; Brenne AT; Seidel C; Baykov V; Waage A; Børset M; Sundan A; Hjertner O
    Haematologica; 2004 Feb; 89(2):174-82. PubMed ID: 15003892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD74 is expressed by multiple myeloma and is a promising target for therapy.
    Burton JD; Ely S; Reddy PK; Stein R; Gold DV; Cardillo TM; Goldenberg DM
    Clin Cancer Res; 2004 Oct; 10(19):6606-11. PubMed ID: 15475450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Requirement of soluble factors produced by bone marrow stromal cells on the growth of novel established human myeloma cell line.
    Aikawa S; Hatta Y; Tanaka M; Kaneita Y; Yasukawa K; Sawada U; Horie T; Tsuboi I; Aizawa S
    Int J Oncol; 2003 Mar; 22(3):631-7. PubMed ID: 12579318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of CD28 on the new myeloma cell line MOLP-8 with t(11;14)(q13;q32) expressing delta/lambda type immunoglobulin.
    Matsuo Y; Drexler HG; Harashima A; Okochi A; Hasegawa A; Kojima K; Orita K
    Leuk Res; 2004 Aug; 28(8):869-77. PubMed ID: 15203285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The RANK/RANK ligand system is involved in interleukin-6 and interleukin-11 up-regulation by human myeloma cells in the bone marrow microenvironment.
    Giuliani N; Colla S; Morandi F; Rizzoli V
    Haematologica; 2004 Sep; 89(9):1118-23. PubMed ID: 15377473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha(v)beta(3) integrin engagement enhances cell invasiveness in human multiple myeloma.
    Ria R; Vacca A; Ribatti D; Di Raimondo F; Merchionne F; Dammacco F
    Haematologica; 2002 Aug; 87(8):836-45. PubMed ID: 12161360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of cyclin D1 mRNA overexpression in B-cell neoplasias by real-time reverse transcription-PCR of microdissected paraffin sections.
    Specht K; Kremer M; Müller U; Dirnhofer S; Rosemann M; Höfler H; Quintanilla-Martinez L; Fend F
    Clin Cancer Res; 2002 Sep; 8(9):2902-11. PubMed ID: 12231535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug-resistant multiple myeloma with high serum levels of lactate dehydrogenase and neutrophil infiltration in pleural effusion].
    Kozawa M; Hata H; Kawaguchi T; Tsuji N; Mori S; Harada N; Nakahashi E; Sakata K; Matsuzaki H; Takatsuki K
    Rinsho Ketsueki; 1994 Jan; 35(1):49-53. PubMed ID: 8139102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Establishment and biological characteristics of human multiple myeloma cell line CZ-1].
    Hou J; Zhang B; Zhang L; Ding S
    Zhonghua Xue Ye Xue Za Zhi; 2002 Oct; 23(10):509-13. PubMed ID: 12482345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment and characterization of a new human Bence Jones-type myeloma cell line, NOP-2.
    Nagai T; Ogura M; Morishita Y; Okumura M; Kato Y; Morishima Y; Hirabayashi N; Ohno R; Saito H
    Int J Hematol; 1991 Apr; 54(2):141-9. PubMed ID: 1747447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of telomerase activity in multiple myeloma.
    Shiratsuchi M; Muta K; Abe Y; Motomura S; Taguchi F; Takatsuki H; Uike N; Umemura T; Nawata H; Nishimura J
    Cancer; 2002 Apr; 94(8):2232-8. PubMed ID: 12001122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative analysis of the anti-apoptotic gene survivin expression in malignant haematopoietic cells.
    Moriai R; Asanuma K; Kobayashi D; Yajima T; Yagihashi A; Yamada M; Watanabe N
    Anticancer Res; 2001; 21(1B):595-600. PubMed ID: 11299811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serum LDH and myeloma. Correlation with the degree of bone marrow infiltration].
    Ogea García JL; Blanco Molina MA; Andrés P; Muñoz R; Jiménez Alonso J; Pérez Jiménez F
    Rev Esp Oncol; 1985; 32(2):207-13. PubMed ID: 3843455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common features and differences in the transcriptome of large cell anaplastic lymphoma and classical Hodgkin's lymphoma.
    Willenbrock K; Küppers R; Renné C; Brune V; Eckerle S; Weidmann E; Bräuninger A; Hansmann ML
    Haematologica; 2006 May; 91(5):596-604. PubMed ID: 16670065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal stromal cells revert multiple myeloma cells to less differentiated phenotype by the combined activities of adhesive interactions and interleukin-6.
    Dezorella N; Pevsner-Fischer M; Deutsch V; Kay S; Baron S; Stern R; Tavor S; Nagler A; Naparstek E; Zipori D; Katz BZ
    Exp Cell Res; 2009 Jul; 315(11):1904-13. PubMed ID: 19328780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneous expression of CD32 and CD32-mediated growth suppression in human myeloma cells.
    Zheng X; Abroun S; Otsuyama K; Asaoku H; Kawano MM
    Haematologica; 2006 Jul; 91(7):920-8. PubMed ID: 16818279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression and clinical significance of beta-catenin in multiple myeloma].
    Li J; Zhang DB; Luo SK; Zhao Y; Huang BH; Gu JL
    Ai Zheng; 2007 Sep; 26(9):1010-4. PubMed ID: 17927863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.